ATE452186T1 - Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit - Google Patents

Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit

Info

Publication number
ATE452186T1
ATE452186T1 AT04748527T AT04748527T ATE452186T1 AT E452186 T1 ATE452186 T1 AT E452186T1 AT 04748527 T AT04748527 T AT 04748527T AT 04748527 T AT04748527 T AT 04748527T AT E452186 T1 ATE452186 T1 AT E452186T1
Authority
AT
Austria
Prior art keywords
aca
cephalosporin
therefrom
producing
acylase mutant
Prior art date
Application number
AT04748527T
Other languages
English (en)
Inventor
Yong Chul Shin
John Yj Jeon
Kyung Hwa Jung
Mi Ran Park
Youngsoo Kim
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36203823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE452186(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE452186T1 publication Critical patent/ATE452186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/02—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
AT04748527T 2003-08-11 2004-08-10 Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit ATE452186T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2003-0055259A KR100530299B1 (ko) 2003-08-11 2003-08-11 변이 세팔로스포린 ｃ 아실라제 및 이를 이용한 7-ａｃａ 제조방법
PCT/KR2004/002005 WO2005014821A1 (en) 2003-08-11 2004-08-10 Cephalosporin c acylase mutant and method for preparing 7-aca using same

Publications (1)

Publication Number Publication Date
ATE452186T1 true ATE452186T1 (de) 2010-01-15

Family

ID=36203823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748527T ATE452186T1 (de) 2003-08-11 2004-08-10 Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit

Country Status (11)

Country Link
US (1) US7592168B2 (de)
EP (1) EP1656450B2 (de)
JP (1) JP2007502108A (de)
KR (1) KR100530299B1 (de)
CN (1) CN1836044B (de)
AT (1) ATE452186T1 (de)
DE (1) DE602004024686D1 (de)
ES (1) ES2338118T5 (de)
PL (1) PL1656450T5 (de)
SI (1) SI1656450T2 (de)
WO (1) WO2005014821A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100530299B1 (ko) 2003-08-11 2005-11-22 산도즈 게엠베하 변이 세팔로스포린 ｃ 아실라제 및 이를 이용한 7-ａｃａ 제조방법
ITMI20040016A1 (it) * 2004-01-12 2004-04-12 Antibiotics S P A Cefalosporina c acilasi
EP2851423B1 (de) 2005-12-28 2016-03-02 DSM Sinochem Pharmaceuticals Netherlands B.V. Mutierte Type II Beta-Laktam-Acylasen
CN102154429A (zh) * 2010-12-28 2011-08-17 哈药集团制药总厂 一步酶法制备7-氨基头孢烷酸
CN102321603B (zh) * 2011-09-30 2013-03-27 清华大学 头孢菌素酰化酶突变体及其编码基因与应用
EP2602264A1 (de) 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH GDF-5-Mutant zur Induzierung der Knorpelbildung
KR101728906B1 (ko) * 2013-01-21 2017-04-20 아미코젠주식회사 세파계 항생제 원료물질(7-aca)을 생산하기 위한 변이효소
CN105018455B (zh) * 2015-08-06 2019-01-04 焦作健康元生物制品有限公司 一种头孢菌素c酰基转移酶的纯化方法
CN105087537B (zh) * 2015-09-16 2018-09-28 艾美科健（中国）生物医药有限公司 一种7-aca固定化酶lk118的制备及其使用方法
CN106119233B (zh) * 2016-07-01 2019-06-07 清华大学 头孢菌素酰化酶突变体及其编码基因与应用
CN108220276B (zh) * 2017-10-30 2021-05-14 南京朗恩生物科技有限公司 一种头孢菌素c酰化酶突变体及其在7-氨基头孢烷酸生产中的应用
CN109913436B (zh) * 2017-12-12 2023-05-23 石药集团圣雪葡萄糖有限责任公司 含有一个或几个点突变的头孢菌素c酰化酶突变体及其制备方法
CN110964772A (zh) * 2018-09-29 2020-04-07 北京科技大学 连续制备7-氨基头孢烷酸的方法
CN110964771A (zh) * 2018-09-29 2020-04-07 北京科技大学 制备7-氨基头孢烷酸的方法
CN110129305B (zh) * 2019-05-28 2022-10-28 河北凯恩利生物技术有限公司 一种用于制备7-aca的头孢菌素c酰化酶突变体
KR102363768B1 (ko) * 2019-11-15 2022-02-16 아미코젠주식회사 세파졸린 생산성이 증가된 페니실린 g 아실라제 변이체 및 이의 이용
CN111172142B (zh) * 2020-02-14 2021-09-28 上海陶宇晟生物技术有限责任公司 一种热稳定性高的头孢菌素c酰化酶突变体
CN112662655B (zh) * 2020-12-29 2022-05-03 山东金城柯瑞化学有限公司 头孢菌素c酰化酶突变体及其制备方法和应用
KR102405289B1 (ko) * 2021-12-24 2022-06-07 아미코젠주식회사 세팔로스포린 c 아실라제 활성을 가지는 폴리펩타이드 및 이의 용도

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60110292A (ja) 1983-11-22 1985-06-15 Asahi Chem Ind Co Ltd セフアロスポリン・アシラ−ゼ産生遺伝情報を担うｄνａ断片
JPS6121097A (ja) 1984-07-10 1986-01-29 Asahi Chem Ind Co Ltd ７−アミノセフアロスポラン酸及びその誘導体の製造法
JPS61152286A (ja) 1984-12-27 1986-07-10 Asahi Chem Ind Co Ltd セフアロスポリンｃアシラ−ゼ産生遺伝情報を担うｄｎａ断片
JPS6248379A (ja) 1985-08-27 1987-03-03 Asahi Chem Ind Co Ltd セフアロスポリンｃアシラ−ゼの製造法
JPS6248380A (ja) 1985-08-28 1987-03-03 Asahi Chem Ind Co Ltd セフアロスポリンｃアシラ−ゼの製造法
US5104800A (en) 1989-06-27 1992-04-14 Merck & Co., Inc. One-step cephalosporin c amidase enzyme
US5229274A (en) 1989-06-27 1993-07-20 Merck & Co., Inc. Gene encoding one step cephalosporin C amidase and expression thereof in recombinant bacillus
KR0171897B1 (ko) 1989-12-27 1999-02-01 후지사와 도모끼찌로 7-아미노세펨 화합물 또는 그 염류의 제조 방법
JPH04228073A (ja) 1990-04-18 1992-08-18 Gist Brocades Nv ペニシリンｇアシラーゼ、それをコードする遺伝子及び該酵素の製造方法
ATE167520T1 (de) 1990-04-18 1998-07-15 Gist Brocades Nv Mutierte beta-lactamacylasegene
ES2020792A6 (es) 1990-08-03 1991-09-16 Antibioticos Sa Un procedimiento enzimatico para la presentacion de acido 7-amino-cefa-losporanico y un procedimiento para expresar la enzima 7b (4-carboxibutanamido) cefalosporinacilasa.
JPH04104792A (ja) 1990-08-22 1992-04-07 Asahi Chem Ind Co Ltd 新規アクレモニウム・クリソゲナム
GB9019724D0 (en) 1990-09-10 1990-10-24 Fujisawa Pharmaceutical Co Cephalosporin c acylase
GB9204439D0 (en) * 1992-02-27 1992-04-15 Fujisawa Pharmaceutical Co A new cephalosporin c acylase
US5351667A (en) * 1992-07-03 1994-10-04 Kaaz Corporation Fuel tank pressurizing apparatus
TW400384B (en) * 1993-11-01 2000-08-01 Fujisawa Pharmaceutical Co A new cephalosporin C acylase
JPH07222587A (ja) 1994-02-09 1995-08-22 Fujisawa Pharmaceut Co Ltd 新規セファロスポリンｃアシラーゼ及びその製造方法
AU3346295A (en) 1994-08-12 1996-03-07 Gist-Brocades B.V. Mutated penicillin g acylase genes
JPH0898686A (ja) 1994-10-03 1996-04-16 Fujisawa Pharmaceut Co Ltd 変異型セファロスポリンｃアシラーゼ及びその製造方法
GB9423212D0 (en) 1994-11-17 1995-01-04 Glaxo Group Ltd Industrial enzymes
GB9424945D0 (en) 1994-12-09 1995-02-08 Fujisawa Pharmaceutical Co A new cephalosporin C acylase
EP0961825B1 (de) 1996-11-05 2008-07-30 Bristol-Myers Squibb Company Mutierte penicillin g acylasen
AU2002256860A1 (en) * 2001-03-14 2002-09-24 Klaus-Peter Koller Variant glutaryl amidase (cephalosporin acylase) and uses thereof
EP1456370A2 (de) 2001-12-27 2004-09-15 DSM IP Assets B.V. Verfahren zur herstellung von einem beta-laktam antibiotikum mittels einer mutierten penicillineacylase
EP1576102A2 (de) 2002-01-28 2005-09-21 Diversa Corporation Amidasen, diese codierende nukleinsäuren und verfahren zu deren herstellung und verwendung
KR100530299B1 (ko) 2003-08-11 2005-11-22 산도즈 게엠베하 변이 세팔로스포린 ｃ 아실라제 및 이를 이용한 7-ａｃａ 제조방법
ITMI20040016A1 (it) * 2004-01-12 2004-04-12 Antibiotics S P A Cefalosporina c acilasi

Also Published As

Publication number Publication date
ES2338118T3 (es) 2010-05-04
EP1656450B1 (de) 2009-12-16
KR100530299B1 (ko) 2005-11-22
SI1656450T2 (sl) 2014-01-31
CN1836044B (zh) 2011-06-22
PL1656450T5 (pl) 2014-04-30
CN1836044A (zh) 2006-09-20
PL1656450T3 (pl) 2010-05-31
WO2005014821A1 (en) 2005-02-17
EP1656450A1 (de) 2006-05-17
JP2007502108A (ja) 2007-02-08
KR20050017832A (ko) 2005-02-23
EP1656450A4 (de) 2007-05-09
US20070207519A1 (en) 2007-09-06
ES2338118T5 (es) 2014-02-20
DE602004024686D1 (de) 2010-01-28
US7592168B2 (en) 2009-09-22
EP1656450B2 (de) 2013-10-30
SI1656450T1 (sl) 2010-04-30

Similar Documents

Publication Publication Date Title
ATE452186T1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
ATE493502T1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
ATE360653T1 (de) Verfahren zur herstellung von polyisobutenen
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
SG158739A1 (en) Aggrecanase molecules
ATE442452T1 (de) Verfahren zur herstellung von beta-hydroxy- aminosäuren und dafür geeignetes enzym
ATE470657T1 (de) Verfahren zur herstellung von isocyanaten
DE602004017867D1 (de) Verbessertes verfahren zur herstellung des coenzyms q-10
DE60332894D1 (de) Verfahren zur Herstellung eines immobilisierten Enzyms
DE60211303D1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
ATE318815T1 (de) Verfahren zur herstellung von enantiomeren von indol-2,3-dion-3-oximderivaten
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
UA91153C2 (ru) Способ получения формы и венлафаксина гидрохлорида
ATE375355T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
NO20020328L (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
WO2002042439A3 (en) Aggrecanase adamts9
ATE344328T1 (de) Verfahren zur herstellung von 1-(3- trifluoromethylphenyl)-propan-2-ol enantiomeren
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
AU4757000A (en) Method of producing methoxyimino acetic amide
SI1594879T1 (sl) Postopek in intermediati za pripravo olanzapina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1656450

Country of ref document: EP